Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2018

01-04-2018 | Original Paper

Should I Convince My Partner to Go on Pre-Exposure Prophylaxis (PrEP)? The Role of Personal and Relationship Factors on PrEP-Related Social Control among Gay and Bisexual Men

Authors: Steven A. John, Tyrel J. Starks, H. Jonathon Rendina, Christian Grov, Jeffrey T. Parsons

Published in: AIDS and Behavior | Issue 4/2018

Login to get access

Abstract

An estimated 35–68% of new HIV infections among gay, bisexual, and other men who have sex with men (GBM) are transmitted through main partnerships. Pre-exposure prophylaxis (PrEP) is highly effective in reducing HIV seroconversion, yet PrEP uptake has been modest. PrEP-naïve GBM with HIV-negative, PrEP-naïve main partners enrolled in One Thousand Strong (n = 409), a U.S. national cohort of GBM, were asked about (1) the importance of partner PrEP use and (2) their willingness to convince their partner to initiate PrEP. On average, participants thought partner PrEP was only modestly important and were only moderately willing to try to convince their partner to initiate PrEP. Personal PrEP uptake willingness and intentions were the strongest indicators of partner PrEP outcomes. Being in a monogamish relationship arrangement (as compared to a monogamous arrangement) and the experience of intimate partner violence victimization were associated with increased willingness to persuade a partner to initiate PrEP.
Literature
1.
CDC. HIV surveillance report, 2015, Volume 27. February 2015.
2.
Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS ONE. 2012;7(11):e50522.CrossRefPubMedPubMedCentral
3.
Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23(9):1153–62.CrossRefPubMed
4.
5.
Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61(10):1601–3.CrossRefPubMedPubMedCentral
6.
Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176(1):75–84.CrossRefPubMedPubMedCentral
7.
Grant RM, Koester KA. What people want from sex and preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):3–9.CrossRefPubMed
8.
Strauss BB, Greene GJ, Phillips G, et al. Exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men. AIDS Behav. 2017;21(5):1288–98.CrossRefPubMed
9.
Hood JE, Buskin SE, Dombrowski JC, et al. Dramatic increase in preexposure prophylaxis use among MSM in Washington state. AIDS. 2016;30(3):515–9.PubMed
10.
Parsons JT, Rendina HJ, Whitfield TH, Grov C. Familiarity with and preferences for oral and long-acting injectable HIV pre-exposure prophylaxis (PrEP) in a national sample of gay and bisexual men in the US. AIDS Behav. 2016;20(7):1390–9.CrossRefPubMedPubMedCentral
11.
Grov C, Rendina HJ, Whitfield TH, Ventuneac A, Parsons JT. Changes in familiarity with and willingness to take preexposure prophylaxis in a longitudinal study of highly sexually active gay and bisexual men. LGBT Health. 2016;3(4):252–7.CrossRefPubMedPubMedCentral
12.
Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clin Infect Dis. 2015;61(10):1590–7.CrossRefPubMedPubMedCentral
13.
Parsons JT, Rendina HJ, Lassiter JM, Whitfield THF, Starks TJ, Grov C. Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: the motivational PrEP cascade. J Acq Immun Def Synd. 2017;74(3):285–92.CrossRef
14.
Rendina HJ, Whitfield THF, Grov CS. T.J., Parsons JT. Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): findings from a large cohort of gay and bisexual men in the U.S. Soc Sci Med. 2017;172:115–23.CrossRefPubMed
15.
16.
Starks TJ, Grov C, Parsons JT. Sexual compulsivity and interpersonal functioning: sexual relationship quality and sexual health in gay relationships. Health Psychol. 2013;32(10):1047–56.CrossRefPubMed
17.
Rusbult CE, Van Lange PA. Interdependence, interaction, and relationships. Annu Rev Psychol. 2003;54:351–75.CrossRefPubMed
18.
Lewis MA, Gladstone E, Schmal S, Darbes LA. Health-related social control and relationship interdependence among gay couples. Health Educ Res. 2006;21(4):488–500.CrossRefPubMed
19.
20.
Grov C, Starks TJ, Rendina HJ, Parsons JT. Rules about casual sex partners, relationship satisfaction, and HIV risk in partnered gay and bisexual men. J Sex Marital Ther. 2014;40(2):105–22.CrossRefPubMed
21.
Hoff CC, Beougher SC, Chakravarty D, Darbes LA, Neilands TB. Relationship characteristics and motivations behind agreements among gay male couples: differences by agreement type and couple serostatus. AIDS Care. 2010;22(7):827–35.CrossRefPubMedPubMedCentral
22.
Parsons JT, Starks TJ, DuBois S, Grov C, Golub SA. Alternatives to monogamy among gay male couples in a community survey: implications for mental health and sexual risk. Arch Sex Behav. 2013;42(2):303–12.CrossRefPubMed
23.
Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43(1):99–106.CrossRefPubMedPubMedCentral
24.
25.
Stephenson R, White D, Darbes L, Hoff CC, Sullivan P. HIV testing behaviors and perceptions of risk of HIV infection among MSM with main partners. AIDS Behav. 2015;19:553–60.CrossRefPubMedPubMedCentral
26.
Mitchell JW, Harvey SM, Champeau D, Seal DW. Relationship factors associated with HIV risk among a sample of gay male couples. AIDS Behav. 2012;16(2):404–11.CrossRefPubMedPubMedCentral
27.
Gamarel KE, Golub SA. Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships. Ann Behav Med. 2015;49(2):177–86.CrossRefPubMedPubMedCentral
28.
Stephenson R, Freeland R, Finneran C. Intimate partner violence and condom negotiation efficacy among gay and bisexual men in Atlanta. Sex Health. 2016;13(4):366.CrossRef
29.
Koester KA, Liu A, Eden C, et al. Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study. AIDS Care. 2015;27(10):1199–204.CrossRefPubMed
30.
Goldenberg T, Stephenson R, Freeland R, Finneran C, Hadley C. ‘Struggling to be the alpha’: sources of tension and intimace partner violece in same-sex relationships between men. Cult Health Sex. 2016;18(8):875–89.CrossRefPubMedPubMedCentral
31.
Rendina HJ, Moody RL, Ventuneac A, Grov C, Parsons JT. Aggregate and event-level associations between substance use and sexual behavior among gay and bisexual men: comparing retrospective and prospective data. Drug Alcohol Depend. 2015;154:199–207.CrossRefPubMedPubMedCentral
32.
Parsons JT, Lelutiu-Weinberger C, Botsko M, Golub SA. Predictors of day-level sexual risk for young gay and bisexual men. AIDS Behav. 2013;17(4):1465–77.CrossRefPubMedPubMedCentral
33.
Parsons JT, Starks TJ. Drug use and sexual arrangements among gay couples: frequency, interdependence, and associations with sexual risk. Arch Sex Behav. 2014;43(1):89–98.CrossRefPubMed
34.
Drumright LN, Patterson TL, Strathdee SA. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse. 2006;41(10–12):1551–601.CrossRefPubMed
35.
Grov C, Parsons JT, Bimbi DS. In the shadows of a prevention campaign: sexual risk behavior in the absence of crystal methamphetamine. AIDS Educ Prev. 2008;20(1):42–55.CrossRefPubMed
36.
Oldenburg CE, Mitty JA, Biello KB, et al. Differences in attitudes about HIV pre-exposure prophylaxis use among stimulant versus alcohol using men who have sex with men. AIDS Behav. 2016;20(7):1451–60.CrossRefPubMedPubMedCentral
37.
Grov C, Cain D, Whitfield TH, et al. Recruiting a U.S. national sample of HIV-negative gay and bisexual men to complete at-home self-administered HIV/STI testing and surveys: challenges and opportunities. Sex Res Soc Policy. 2016;13(1):1–21.CrossRef
38.
Grov C, Cain D, Rendina HJ, Ventuneac A, Parsons JT. Characteristics associated with urethral and rectal gonorrhea and chlamydia diagnoses in a US national sample of gay and bisexual men: results from the One Thousand Strong panel. Sex Transm Dis. 2016;43(3):165–71.CrossRefPubMedPubMedCentral
39.
Parsons JT, Starks TJ, Gamarel KE, Grov C. Non-monogamy and sexual relationship quality among same-sex male couples. J Fam Psychol. 2012;26(5):669–77.CrossRefPubMed
40.
Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185–99.CrossRefPubMed
41.
42.
Bohn MJ, Babor TF, Kranzler HR, editors. Validity of the Drug Abuse Screening Test (DAST-10) in inpatient substance abusers: problems of drug dependence. In: 53rd Annual Scientific Meeting from the Committee on Problems of Drug Dependence Inc; 1991. Rockville, MD: Department of Health and Human Services; 1992.
43.
Greenwood GL, Relf MV, Huang B, Pollack LM, Canchola JA, Catania JA. Battering victimization among a probability-based sample of men who have sex with men. Am J Public Health. 2002;92(12):1964–9.CrossRefPubMedPubMedCentral
44.
Stall R, Mills TC, Williamson J, et al. Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. 2003;93(6):939–42.CrossRefPubMedPubMedCentral
45.
Sullivan PS, White D, Rosenberg ES, et al. Safety and acceptability of couples HIV testing and counseling for US men who have sex with men: a randomized prevention study. J Int Assoc Physicians AIDS Care. 2014;13(2):135–44.CrossRef
46.
Duncan DT, Goedel WC, Stults CB, et al. A study of intimate partner violence, substance abuse, and sexual risk behaviors among gay, bisexual, and other men who have sex with men in a sample of geosocial-networking smartphone application users. Am J Mens Health. 2016.
47.
48.
Beymer MR, Weiss RE, Halkitis PN, et al. Disparities within the disparity-determining HIV risk factors among latino gay and bisexual men attending a community-based clinic in Los Angeles. CA. J Acq Immun Def Synd. 2016;73(2):237–44.CrossRef
49.
Goldenberg T, Finneran C, Andes KL, Stephenson R. ‘Sometimes people let love conquer them’: how love, intimacy, and trust in relationships between men who have sex with men influence perceptions of sexual risk and sexual decision-making. Cult Health Sex. 2015;17(5):607–22.CrossRefPubMed
50.
Ware NC, Wyatt MA, Haberer JE, et al. What’s love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acq Immun Def Synd. 2012;59(5):463–8.CrossRef
Metadata
Title
Should I Convince My Partner to Go on Pre-Exposure Prophylaxis (PrEP)? The Role of Personal and Relationship Factors on PrEP-Related Social Control among Gay and Bisexual Men
Authors
Steven A. John
Tyrel J. Starks
H. Jonathon Rendina
Christian Grov
Jeffrey T. Parsons
Publication date
01-04-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1835-1

Other articles of this Issue 4/2018

AIDS and Behavior 4/2018 Go to the issue

Original Paper

Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China

Original Paper

A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis

Original Paper

High Burden of HIV, Syphilis and HSV-2 and Factors Associated with HIV Infection Among Female Sex Workers in Tanzania: Implications for Early Treatment of HIV and Pre-exposure Prophylaxis (PrEP)

Original Paper

Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value

Original Paper

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants

Original Paper

At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits